Poster Presentations

Poster Presentations

The Poster Presentation session will take place on Saturday, February 14 from 16:45 till 18:00 in Potsdam II hall (exhibition and poster area, next to the lecture hall).

  • Posters must be mounted on Friday, Feb.13TH, from 10:00 and no later than 15:30 (preferably as early as possible). 
  • Posters must be manned during the Poster Presentation Session.
  • Posters should be dismounted on Saturday, Feb.15TH, after the scientific program concludes at 15:30, and no later than 19:00 that evening.
  • Double sided tape and technical equipment will be available for the mounting of posters.
  • Please use the board with the same number of your poster in the Poster Presentation List.

No.

TITLE

P-01

Thromboembolism prophylaxis after cesarean section (PRO-CS) trial

F.H. AlGahtani, H. Al-Dohami, S. Abo-Harbesh, A. Al-Gader, A. Aleem (Saudi Arabia)

P-02

Effects of new oral anticoagulants (NOAC) on different antithrombin assays

E-M. Norberg, L. Söderblom, M. Berndtsson, M. Skeppholm, J. Antovic (Sweden)

P-03

Management of major obstetric haemorrhages over a 10- year period using an acute massive blood loss (AMBL) protocol

J. Garry, J. McNamee, A. Fortune, M. McCloy, J. Sargent (Ireland)

P-04

Validation of screening tool for bleeding disorders in women with heavy menstrual bleeding

S. Wiewel-Verschueren, H.M. Knol, A.B. Mulder, E.R. Klinkert, H.C. Kluin-Nelemans, A.G.J. van der Zee, K. Meijer (Netherlands)

P-05

Thyroid function in women with heavy menstrual bleeding

S. Wiewel-Verschueren, H.M. Knol, A.B. Mulder, E.R. Klinkert, H.C. Kluin-Nelemans, A.G.J. van der Zee, K. Meijer (Netherlands)

P-06

Anticoagulant therapy for acute venous thromboembolism during pregnancy: case-control study of delivery and post-partum E. Le Moigne, S. Georget, M. Collet, M. Jacquot, C. Tromeur, D. Mottier, A. Delluc (France)

P-07

Midwife and obstetric doctors’ views of venous thromboembolism (VTE) in the puerperium  

B. Guimicheva, L.N. Roberts, J.P. Patel, D. Subramanian, R. Arya (UK)

P-08

Hypercoagulation and pre-eclampsia: prospective study of thrombin potential generation in a population of women with pre-eclampsia L. Masson, C. Caron, C. Vermersch, V. Houfflin-Debarge, A-S. Ducloy-Bouthors (France)

P-09

Clinical improvement and successful pregnancy in three patients with antiphospholipid antibodies and ischemic placental disease treated with pravastatin

E. Lefkou, A. Mamopoulos, T. Dagklis, C. Vosnakis, C. Anthoulakis, G. Mavromatidis, D. Rousso, G. Girardi (Greece, UK)

P-10

Right ventricular thrombus mimicking recurrent myxoma in a woman with antiphospholipid syndrome

E. Lefkou, T. Karamitsos,  A. Machtopoulou, A. Theodoridou, G. Gerotziafas, B. J. Hunt (Greece, UK)

P-11

Thrombin generation, D-dimer and protein S in normal uncomplicated pregnancy

M. Kovac, S. Lalic-Cosic,  V. Djordjevic, D. Radojkovic (Serbia)

P-12

Evaluation of the method of thrombodynamics in pregnant women with complicated obstetric history for haemostasis monitoring J. Pavlovskaia, N. Vorobyeva (Russia)

P-13

Role of genetic polymorphisms of haemostasis's system in case of habitual miscarriage

D. Gamyrkina, N. Vorobyeva (Russia)

P-14

Hemolytic anemia in HELLP syndrome: a link with kidney injury?

L. Sabau, J. Biernat, F. Provôt, F. Fourrier, A.S. Ducloy-Bouthors (France)

P-15

Does preeclampsia induced excessive thrombin generation predict maternal or foetal severe outcome?

C. Vermersch, L. Masson, V. Debarge, C. Caron, V. Deken, A-S. Ducloy-Bouthors (France)

P-16

The role of the common M2/ANXA5 haplotype as a predisposition factor in malay recurrent miscarriage women and couples. A pilot study T.T. Hock, N. Bogdanova, A. Kai Cheen, S. Kathirgamanathan, R. bin Abdullah, N. Mohd Yusoff, W. Zaidah Abdullah, F.S. Abdul Manaf, P. Wieacker, A. Markoff (Malaysia, Germany)

P-17

The management of Bernard-Soulier syndrome in pregnancy – a case report

R. Halabi, E. Horn, E. Ciantar (UK)

P-18

The management of Factor XIII deficiency in pregnancy – a case report

S. Dukka, E. Horn, E. Ciantar (UK)

P-19

Primary immune thrombocytopenia (ITP) in pregnancy. An audit on its management in a large tertiary unit

O. Al Shakhshir, S. Hensch, S. Rajesh, Q. Hill, E. Ciantar (UK)

P-20

Polymorphism in SG319 gene reverse cholesterol transporter ABCA1 as a marker of favorable development of coronary artery disease in young and middle-aged women

T. Vavilova, V. Feoktistova, O. Sirotkina, S. Boldueva, I. Leonova, L. Gaykovaya (Russia)

P-21

Cardiac X syndrome. Does endothelial dysfunction play an important role?

I. Leonova, A. Lipunova, S. Boldueva, M. Kolesnichenko, T. Vavilova, V. Feoktistova (Russia)

P-22

Impact of hydroxychloroquine treatment on pregnancy outcome in patients with antiphospholipid antibodies

S. Sciascia, E. Talavera, BJ. Hunt, G. Lliso, MA. Khamashta, MJ. Cuadrado (UK)

P-23

FXI, pregnancy and blood group

B. Myers, R. Kadir, R. Neal & S. Pavord (UK)

P-24

Management of thromboprophylaxis in pregnant women with known thrombophilia or vascular placental complications (VPC) and delivery. Preliminary results of the team project

D. Mussio, E. Martí, C. Medina, M. Casellas, M. Stevenazzi, A. Redondo Izal, I. de Diego, A. Rodríguez Huerta, P. Llamas, J. Rodríguez Martorell, O. Martínez, I.M. Ramírez, M. J. Gutiérrez Pimentel, D. Tássies, A. Santamaría (Uruguay, Spain)

P-25

Thrombophilia in pregnant women with thrombosis and placental vasuclar complications

D. Mussio, L. Pons V. Lopez-Andreoni, P. Olivera, R. Robaina, S. Grille, M. Stevenazzi, F. Bosch, A. Santamaría (Uruguay, Spain)

P-26

Should the couple be screened for thrombophilia after a diagnosis of perinatal stroke?

S. Pinho, J. Lima, S. Sarzedas, M. Lucas, G. Carvalhosa, C. Telhado, A. Serrão Neto (Portugal)

P-27

Risk factors for unexplained intrauterine fetal death in Northern Greece: A retrospective case control study

C. Anthoulakis, A. Mamopoulos, S. Aggelidou, T. Dagklis, I. Famellos, E. Lefkou, I. Tsakiridis, G. Mavromatidis,

D. Rousso (Greece)

P-28

Cardiac output and microcirculatory reactivity in preeclamptic patient : a non-invasive comparative prospective study

M. Gonzalez Estevez, S. Langlois, L. Masson, C. Vermeersch, A-S. Ducloy-Bouthors, V. Houfflin-Debarge, P. Richart,

B. Vallet (France)

P-29

High thrombotic risk in pregnancy and obstetric outcomes - a tertiary hospital reality

S. Oliveira, M. Guimarães (Portugal)

P-30

Portal vein thrombosis in patient with gastric diffuse B large cell lymphoma

D. Antic, V. Djurasinovic, V. Vukovic, B. Mihaljevic (Serbia)

P-31

Menorrhagia associated with rivaroxaban therapy

N.J. Dolan, K.A. Breen, B.J. Hunt (UK)

P-32

Recurrence of VTE, obstetric and neonatal outcomes in 78 women with venous thromboembolism during pregnancy and puerperium - M. Revelj, A. Hagman, M. Hellgren (Sweden)

P-33

The difference in significance between antiphospholipid syndrome and antiphospholipid antibodies present in pregnant women with thrombosis and/or pregnancy complications

N.K. Vereina, S.P. Sinitsin, V.F. Dolgushina, V.S. Chulkov (Russia)

P-34

Hypercoagulability increases during pregnancy in women receiving prophylactic low-molecular-weight heparin

M. Božič Mijovski, T. Vižintin Cuderman, S. Šmid, M. Kozak (Slovenia)

P-35

The LMWH-associated early variations in circulating angiogenic factors predict clinical outcomes in pregnant women with previous placental abruption or severe pre-eclampsia

S. Bouvier, G. Lavigne, E. Nouvellon, E. Mercier, J-P. Balducchi, J-Y. Lefrant, E. Mousty, P. Marès, J-C. Gris (France)

P-36

Circulating microparticles in cord blood of normal pregnancy and of pregnancy with preeclampsia

E. Campello, L. Spiezia, C. M. Radu, S. Visentin, S. Gavasso, S. Maggiolo, E. Cosmi, P. Simioni (Italy)

P-37

Circulating microparticles in normal pregnancy: a longitudinal study

E. Campello, C. M. Radu, L. Spiezia, S. Dhima, S. Visentin, S. Gavasso, B. Woodhams, E. Cosmi, P. Simioni (Italy)

P-38

Whole blood thromboelastometry profiles in women with preeclampsia

L. Spiezia, E. Campello, G. Bogana, S. Maggiolo, C. M. Radu, C. Bulato, M. T. Gervasi, P. Simioni (Italy)

P-39

Frequency of antiphospholipid syndrome in 600 Czech women with venous thromboembolism in association with combined oral contraceptive use - P. Dulíček, E. Ivanová, P. Sadílek, P. Žák (Czech Republic)

P-40

Management of childbirth in a patient with severe factor V deficiency and congenital cardiomyopathy

S. Vander Meeren, M. Laubach, D. Kerkhove, K. Jochmans (Belgium)

P-41

Secondary prevention of thromboembolic recurrences in pregnant women at high risk of recurrence: a French survey

A. Buchmuller, C. Chauleur, S. Middeldorp, A. Merah, S. Accassat, M. Bardou, H. Decousus, B. Tardy (France, Netherlands)

P-42

Massive splenic infarction during puerperium in a sickle cell β thalassemia patient

C. Levin, T. Dujovny, A. Koren (Israel)

P-43

Thrombolysis of massive pulmonary embolism during pregnancy; A case-report and literature review

G. Martillotti, P. Fontana, F. Boehlen, M. Righini, M. Boulvain, N. Jastrow, N. Dufresne, P. Meyer, S. Terraz, M. Blondon (Switzerland)

P-44

A possible role of low-molecular-weight-heparins in the placental balance between haemostasis and angiogenesis

M. Villani, E. Chinni, N. Sciannamè, E. Mangiullo, L. Tiscia, G. Favuzzi, F. Cappucci, F. Petruzzelli, M. Margaglione,

E. Grandone (Italy)

P-45

Heavy menstrual bleeding on rivaroxaban – 2 years of experience

M.S. Ferreira, S. Barsam, J.P. Patel, J. Czuprynska, L.N. Roberts, R.K. Patel, R. Arya (UK, Portugal)

P-46

Severe von Willebrand disease (VWD) in pregnancy and childbirth: a case series

M. Malina, R. Abdul-Kadir, D. Pollard, M. Siebert and S. Halimeh (UK, Germany)

P-47

D-dimer is not an effective tool in the diagnosis of venous thromboembolism in pregnancy, 6 years of experience at a tertiary medical center - A. Keren-Politansky, I. Solt (Israel)

P-48

A reference laboratory experience in the diagnosis of neonatal alloimmune thrombocytopenia

L. Bonstein, I. Solt (Israel)

P-49

Impact of Factor VII deficiency compared to Von Willebrand disease on gyneco-obstetrical bleeding

C. Lavoie, C. Taillefer, M. David, R. Winikoff (Canada)

P-50

Obstetric Antiphospholipid Syndrome: The influence of triple positivity antibodies profile on pregnancy outcomes

J.O. Latino, R.D. Fernandez, U. Sebastian (Argentina)

P-51

Antiphospholipid antibodies circulation and fetal loss syndrome

J. Khizroeva, D. Kapanadze, M. Andreeva, G. Abramyan (Russia)

P-52

Antiphospholipid antibodies circulation in patients undergoing IVF

J. Khizroeva, V. Bitsadze, N. Makatsariya (Russia)

P-53

Unclear case of recurrent thrombosis in pregnancy: Role of acquired ADAMTS-13 deficiency

V.O. Bizadze, A.D. Makatsariya, S.V. Akinshina (Russia)

P-54

Prevention of recurrent venous and arterial thromboembolic complications during pregnancy

S.V. Akinshina, A.D. Makatsariya, V.O. Bitsadze, M. Andreeva, N. Stuleva (Russia)

P-55

Perinatal outcomes in women with history of stroke and thrombophilia

A.D. Makatsariya, S.V. Akinshina, V.O. Bitsadze (Russia)

P-56

Pathogenetic prophylaxis pre-eclampsia in patients with thrombophilia and pre-eclampsia in anamnesis

A.D. Makatsariya, E.V. Zhuravleva, M.D. Andreeva (Russia)

P-57

Anticoagulation therapy in cancer patients

A. Makatsariya; A. Vorobev (Russia)

P-58

Rare localisation trombosis in cancer patients

A. Makatsariya; A. Vorobev (Russia)

P-59

Abnormal uterine bleeding as the first manifestation of hemostasis system abnormalities

R.A. Saidova, A.D. Makatsariya (Russia)

P-60

Factor XIII VAL34LEU polymorphism is a possible risk factor for venous thromboembolism in young women from the North-Western region of Russia - S. Kapustin, V. Shmeleva, N. Saltykova, J. Sidorova, V. Soldatenkov, L. Papayan (Russia)

Stay tuned for updates regarding the upcoming virtual convention on October 2021